EVALUATION OF ANTIDEPRESSANT ACTIVITY OF HERBOMINERAL FORMULATION

  • Snehal S. Patel Institute of Pharmacy, Nirma University, Sarkhej Gandhinagar Highway, Ahmedabad-382481 Gujarat, India
  • Niti Rajshree
  • Praboth V. Shah

Abstract

Objective: In the search for new therapeutic products for the treatment of neurological disorders, medicinal plant research, worldwide, has constantly progressed, demonstrating the pharmacological effectiveness of different plant species in a variety of animal models. SOBEREX CAPSULE (SC) is a herbomineral formulation used by ayurvedic practitioners for treatment of depression. The present study was designed to generate scientific evidence for SC in animal models of depression in mice.

Methods: The formulation was administered orally to the mice at a dose of 50 mg/kg for 14 d, and at the end of treatment animals were subjected to tail suspension test and the forced swimming test in mice.

Results: The effect of SC at the dose of 50 mg/kg was comparable to that of reference antidepressant fluoxetine. The formulation and fluoxetine, at the doses tested, produced no significant effects on locomotor activity. These results demonstrated that SC had antidepressant effects without side effect.

Conclusion: Thus, SC possesses antidepressant-like effects in mice, providing further support for the traditional use of the formulation against central nervous disorders.

Keywords: Antidepressant, Herbomineral formulation, Forced swim test, Tail suspension test

Downloads

Download data is not yet available.

References

1. Velumurugan C, Muthuramu T, Venkatesh S, Vetriselvan S. Antidepressant activity of ethanolic extract of the bark of Ougeinia oojeinensis (roxb.) in mice. Int J Biol Pharm Res 2013;4:382-5.
2. Yu ZF, Kong LD, Chen Y. Antidepressant activity of aqueous extracts of Curcuma longa in mice. J Ethnopharmacol 2002;83:161-5.
3. Pawar DB, Marathe PA, Rege NN. Antidepressant activity of aqueous extracts of fruits of Terminalia chebula and Phyllanthus emblica in behavioral models of depression: involvement of monoaminergic system. Int J Pharm Pharm Sci 2014;6:615-20.
4. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977;266:730-2.
5. Steru L, Chermat R, Thierry B, Simon P. The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology 1985;85:367-70.
6. Dhingra D, Valecha R. Evaluation of the antidepressant-like activity of Convolvulus pluricaulis choisy in the mouse forced swim and tail suspension tests. Medical science monitor: Int Med J Exp Clin Res 2007;13:155-61.
7. O’Donnell JM, Shelton RC. Drug therapy of depression and anxiety disorders. Brunton LL, Chabner BA, Knollmann BC, editors. In: Goodman and Gilman's: The Pharmacological Basis of Therapeutics. 12th ed. New York: McGraw-Hill; 2011. p. 397-416.
8. Gold PW, Goodwin FK, Chrousus GP. Clinical and biochemical manifestations of depression in relation to the neurobiology of stress: Part 1. N Engl J Med 1988;319:348–53.
9. Donoghue JM, Tylee A. The treatment of depression: prescribing patterns of antidepressants in primary care in the UK. Br J Psychiatry 1996;168:164–8.
10. Butterweck V, Petereit F, Winterhoff H, Nahrstedt A. Solubilized hypericin and pseudo-hypericin from hypericum perforatum exert antidepressant activity in the forced swimming test. Planta Med 1998;64:291–4.
11. Dhingra D, Goyal PK. Inhibition of MAO and GABA: probable mechanisms for the antidepressant-like activity of Nardostachys jatamansi DC. in mice. Indian J Exp Biol 2008;46:212-8.
12. Mombereau C, Kaupmann K, Froestl W, Sansig G, van der Putten H, Cryan JF. Genetic and pharmacological evidence of a role for GABA(B) receptors in the modulation of anxiety and antidepressant-like behavior. Neuropsychopharmacol 2004;29:1050-62.
13. Prabhu V, Karanth KS, Rao A. Effects of Nardostychas jatamsnsi on biogenic amines and inhibitory amino acids in the rat brain. Planta Med 1994;60:114-7.
14. Tripathi AK, Singh RH. Experimental evaluation of the antidepressant effect of Vacha (Acorus calamus) in animal models of depression. Ayu 2010;31:153-8.
15. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycol withanolides an experimental study. Phytomed: Int J Phytother Phytopharmacology 2000;7:463-9.
16. Aggarwal BB, Prasad S, Reuter S. Identification of novel anti-inflammatory agents from ayurvedic medicine for prevention of chronic diseases: “Reverse Pharmacology” and “Bedside to Bench” Approach. Curr Drug Targets 2011;12:1595-653.
17. Dhingra, Valecha. Antidepressant-like activity of Celastrus paniculatus seed oil in mice subjected to chronic unpredictable mild stress. Br J Pharm Res 2014;4:576-93.
18. Xu Z, Zhang Y, Hou B, Gao Y, Wu Y, Zhang C. Chronic corticosterone administration from adolescence through early adulthood attenuates depression-like behaviors in mice. J Affective Disord 2011;131:128–35.
19. Patil AD, Patil AY, Raje AA. An antidepressant like property of Hyoscyamus niger linn. in a mouse model of depression. Innovations Pharm Pharmacother 2013;1:60-9.
20. Sairam K, Dorababu M, Goel RK, Bhattacharya SK. Antidepressant activity of standardized extract of Bacopa monniera in experimental models of depression in rats. Phytomedicine 2002;9:207-11.
21. Freis ED. Mental depression in hypertensive patients treated for long periods with large doses of reserpine. N Engl J Med 1954;251:1006-8.
22. Kenner D. Using aromatics in clinical practice. California J Oriental Med 1998;9:30-2.
Statistics
239 Views | 814 Downloads
How to Cite
Patel, S. S., N. Rajshree, and P. V. Shah. “EVALUATION OF ANTIDEPRESSANT ACTIVITY OF HERBOMINERAL FORMULATION”. International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, no. 4, Apr. 2016, pp. 145-7, https://innovareacademics.in/journals/index.php/ijpps/article/view/6123.
Section
Original Article(s)